Beam Therapeutics
BEAM
BEAM
232 hedge funds and large institutions have $3.63B invested in Beam Therapeutics in 2021 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 74 increasing their positions, 70 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
7% less call options, than puts
Call options by funds: $17.1M | Put options by funds: $18.5M
1.24% less ownership
Funds ownership: 68.09% → 66.84% (-1.2%)
8% less capital invested
Capital invested by funds: $3.93B → $3.63B (-$306M)
Holders
232
Holding in Top 10
5
Calls
$17.1M
Puts
$18.5M
Top Buyers
| 1 | +$91M | |
| 2 | +$43.6M | |
| 3 | +$43.3M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$31.9M |
| 5 |
State Street
Boston,
Massachusetts
|
+$22.4M |
Top Sellers
| 1 | -$126M | |
| 2 | -$62.2M | |
| 3 | -$46.8M | |
| 4 |
Two Sigma Investments
New York
|
-$15.2M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$11.6M |